Human Interleukin-2 Market

The main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and ascites.

Human Interleukin-2 Market contains market size and forecasts of Human Interleukin-2 (IL-2) in global, including the following market information:

Global Human Interleukin-2 (IL-2) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Interleukin-2 (IL-2) Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Human Interleukin-2 (IL-2) companies in 2021 (%)

The global Human Interleukin-2 (IL-2) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50000 U Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Interleukin-2 (IL-2) include Roche, BMS, Schering-Plough, AbbVie Inc, Alkermes Plc, APT Therapeutics, Mabtech Limited, Philogen and Sinopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Interleukin-2 (IL-2) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Interleukin-2 (IL-2) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Human Interleukin-2 (IL-2) Market Segment Percentages, by Type, 2021 (%)

50000 U

100000 U

200000 U

500000 U

1 Million U

2 Million U

Global Human Interleukin-2 (IL-2) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Human Interleukin-2 (IL-2) Market Segment Percentages, by Application, 2021 (%)

Recombinant Interferon

Recombinant Interleukin

Natural Biological Products

Poison Immune

Gene Therapy

Monoclonal Antibody

Global Human Interleukin-2 (IL-2) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Human Interleukin-2 (IL-2) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Interleukin-2 (IL-2) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Interleukin-2 (IL-2) revenues share in global market, 2021 (%)

Key companies Human Interleukin-2 (IL-2) sales in global market, 2017-2022 (Estimated), (KG)

Key companies Human Interleukin-2 (IL-2) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

BMS

Schering-Plough

AbbVie Inc

Alkermes Plc

APT Therapeutics

Mabtech Limited

Philogen

Sinopharm

Jiangsu Jinsili Pharmaceutical

Shenyang Sansheng Pharmaceutical

Beijing Shuanglu Pharmaceutical

Shandong Quangang Pharmaceutical

Shanghai Huaxin Biological high-tech

Beijing Yuance Pharmaceutical

Beijing Sihuan Biological Pharmaceutical

Beijing Sanyuan Gene Pharmaceutical

Shenzhen Kexing Biological Engineering

Shanghai Sanwei Biotechnology

Xiamen Tebao Biological Engineering

Chengdu huashen Biotechnology

Shanghai Pharma Group

Guangdong Xinghao Pharmaceutical